Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Thyrocare Technologies Management Change

Thyrocare Technologies' Chief Scientific Officer, Dr. Preet Kaur, resigns effective November 6, 2026. The company is identifying a replacement and will disclose details later.

Source

BSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Thyrocare Technologies Ltd: key numbers

Share price
₹494.00
Market cap
₹7,863 Cr
Revenue (annual)
₹829.0 Cr
Net profit (annual)
₹163.0 Cr
P/E (TTM)
54.5×Sector 53.4×
Promoter holding
51.02%-9.90% QoQ
FII holding
9.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Thyrocare Technologies Ltd

All →

Other management change announcements

All →